Inotek Pharmaceuticals Corp. Company Profile (NASDAQ:ITEK)

About Inotek Pharmaceuticals Corp.

Inotek Pharmaceuticals Corp. logoInotek Pharmaceuticals Corporation is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. Its lead product candidate, trabodenoson, is a selective adenosine mimetic that the Company has designed to lower intraocular pressure (IOP) by restoring the eye's natural pressure control mechanism. The Company developed this molecule to selectively stimulate a particular adenosine subreceptor in the eye with the effect of augmenting the intrinsic function of the eye's trabecular meshwork (TM). Its product pipeline includes trabodenoson monotherapy delivered in an eye drop formulation, as well as a fixed-dose combination (FDC), of trabodenoson with latanoprost given once-daily (QD). The Company is evaluating the potential of trabodenoson to slow the loss of vision associated with glaucoma and degenerative retinal diseases.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ITEK
  • CUSIP:
Key Metrics:
  • Previous Close: $9.26
  • 50 Day Moving Average: $7.68
  • 200 Day Moving Average: $8.24
  • 52-Week Range: $5.81 - $13.36
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -5.21
  • P/E Growth: 0.00
  • Market Cap: $255.30M
  • Outstanding Shares: 26,930,000
  • Beta: 4.19
Profitability:
  • Return on Equity: -30.98%
  • Return on Assets: -29.74%
Debt:
  • Current Ratio: 24.25%
  • Quick Ratio: 24.25%
Additional Links:
Companies Related to Inotek Pharmaceuticals Corp.:

Analyst Ratings

Consensus Ratings for Inotek Pharmaceuticals Corp. (NASDAQ:ITEK) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $23.00 (142.62% upside)

Analysts' Ratings History for Inotek Pharmaceuticals Corp. (NASDAQ:ITEK)
Show:
DateFirmActionRatingPrice TargetDetails
9/20/2016HC WainwrightInitiated CoverageBuy$22.00View Rating Details
8/16/2016Piper Jaffray Cos.Reiterated RatingBuy$24.00View Rating Details
5/14/2016Canaccord GenuityReiterated RatingBuyView Rating Details
7/24/2015NomuraReiterated RatingBuy$13.00 -> $30.00View Rating Details
7/24/2015Cowen and CompanyReiterated RatingOutperform$15.00 -> $40.00View Rating Details
(Data available from 10/1/2014 forward)

Earnings

Earnings History for Inotek Pharmaceuticals Corp. (NASDAQ:ITEK)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/7/2016        
8/10/2016Q2($0.40)($0.33)ViewN/AView Earnings Details
5/11/2016Q1($0.22)($0.38)ViewN/AView Earnings Details
3/23/2016Q4($0.37)($0.13)ViewN/AView Earnings Details
5/15/2015Q115($0.40)($0.21)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Inotek Pharmaceuticals Corp. (NASDAQ:ITEK)
Current Year EPS Consensus Estimate: $-1.74 EPS
Next Year EPS Consensus Estimate: $-1.82 EPS

Dividends

Dividend History for Inotek Pharmaceuticals Corp. (NASDAQ:ITEK)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Inotek Pharmaceuticals Corp. (NASDAQ:ITEK)
Insider Ownership Percentage: 11.70%
Institutional Ownership Percentage: 73.35%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/13/2016J Martin CarrollDirectorBuy10,000$9.03$90,300.00View SEC Filing  
2/23/2015Argeris N KarabelasDirectorBuy603,832$6.00$3,622,992.00View SEC Filing  
2/23/2015Park Bioventures Lp DevonMajor ShareholderBuy814,166$6.00$4,884,996.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Inotek Pharmaceuticals Corp. (NASDAQ:ITEK)
DateHeadline
finance.yahoo.com logoInotek Pharmaceuticals Appoints Timothy Barberich to Board of Directors - Yahoo Finance (NASDAQ:ITEK)
finance.yahoo.com - September 30 at 5:55 PM
News IconInotek Pharmaceuticals Corporation (ITEK) Updated Broker Ratings - NewsDen (NASDAQ:ITEK)
newsden.net - September 30 at 5:55 PM
businesswire.com logoInotek Pharmaceuticals Appoints Timothy Barberich to Board of Directors - Business Wire (press release) (NASDAQ:ITEK)
www.businesswire.com - September 29 at 5:40 PM
businesswire.com logoInotek Pharmaceuticals Appoints Timothy Barberich to Board of Directors (NASDAQ:ITEK)
www.businesswire.com - September 29 at 10:46 AM
News IconInotek Pharmaceuticals Corporation (ITEK) Latest Broker Coverage - NewsDen (NASDAQ:ITEK)
newsden.net - September 28 at 10:34 AM
investornewswire.com logoAnalysts Expect Inotek Pharmaceuticals Corporation (NASDAQ:ITEK) To Post EPS Of $-0.42 - Investor Newswire (NASDAQ:ITEK)
www.investornewswire.com - September 22 at 3:51 PM
finance.yahoo.com logoCoverage initiated on Inotek Pharmaceuticals by H.C. Wainwright (NASDAQ:ITEK)
finance.yahoo.com - September 20 at 10:48 AM
News Icon2 Sizzling Hot Biotechnology Stocks: Asterias Biotherapeutics, Inc. (AST), Inotek Pharmaceuticals Corporation (ITEK) - The Independent Republic (NASDAQ:ITEK)
theindependentrepublic.com - September 16 at 9:38 AM
News IconGreat Day for Biotech's (NASDAQ:ITEK)
www.fxstreet.com - September 15 at 8:55 AM
thestreet.com logo7 Stocks Under $10 Making Big Moves Higher (NASDAQ:ITEK)
www.thestreet.com - September 15 at 8:55 AM
News IconInotek Announces Participation At Upcoming Investor Conferences (NASDAQ:ITEK)
www.biospace.com - September 6 at 5:42 PM
publicnow.com logoInotek Pharmaceuticals Announces Participation at Upcoming Investor Conferences (NASDAQ:ITEK)
www.publicnow.com - September 6 at 10:29 AM
News IconStock Gapping to the Downside Pre-Market: Inotek Pharmaceuticals Corporation (NASDAQ:ITEK) - Post News (NASDAQ:ITEK)
www.kentuckypostnews.com - September 1 at 5:35 PM
insidermonkey.com logoInotek Pharmaceuticals Corp (ITEK): Billionaire Ken Griffin’ Citadel Investment Group Raises Stake to 6.5% (NASDAQ:ITEK)
www.insidermonkey.com - August 30 at 5:45 PM
News IconInotek Pharmaceuticals Announces the Completion of the Recruitment Phase of MATrX-1, the First Phase 3 Clinical Trial of Trabodenoson for Glaucoma (NASDAQ:ITEK)
www.bioportfolio.com - August 24 at 8:49 AM
finance.yahoo.com logoKalytera Therapeutics Appoints Dr. Andrew Salzman as Chief Medical Officer (NASDAQ:ITEK)
finance.yahoo.com - August 23 at 10:06 AM
finance.yahoo.com logoINOTEK PHARMACEUTICALS CORP Financials (NASDAQ:ITEK)
finance.yahoo.com - August 20 at 5:34 PM
investornewswire.com logoWill Inotek Pharmaceuticals Corporation (NASDAQ:ITEK) Hit $40 Price Target? - Investor Newswire (NASDAQ:ITEK)
www.investornewswire.com - August 20 at 9:53 AM
News IconInotek Appoints To Board Of Directors (NASDAQ:ITEK)
www.biospace.com - August 19 at 8:42 AM
News IconShares Moving Lower Over the Past Month Inotek Pharmaceuticals Corporation (NASDAQ:ITEK) - Post News (NASDAQ:ITEK)
www.kentuckypostnews.com - August 18 at 5:44 PM
streetinsider.com logoForm 8-K INOTEK PHARMACEUTICALS For: Aug 17 (NASDAQ:ITEK)
www.streetinsider.com - August 18 at 8:45 AM
publicnow.com logoInotek Pharmaceuticals Appoints Patrick Machado, JD, to Board of Directors (NASDAQ:ITEK)
www.publicnow.com - August 18 at 8:45 AM
biz.yahoo.com logoINOTEK PHARMACEUTICALS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E (NASDAQ:ITEK)
biz.yahoo.com - August 18 at 8:45 AM
News IconAllergan Pays $95M for ForSight VISION5, Eye Insert for Glaucoma (NASDAQ:ITEK)
www.xconomy.com - August 11 at 5:56 PM
News IconInotek Reports Second Quarter 2016 Financial Results And Operational Highlights (NASDAQ:ITEK)
www.biospace.com - August 10 at 6:00 PM
finance.yahoo.com logoInotek Pharmaceuticals reports 2Q loss - Yahoo Finance (NASDAQ:ITEK)
finance.yahoo.com - August 10 at 8:36 AM
sg.finance.yahoo.com logoInotek Pharmaceuticals reports 2Q loss (NASDAQ:ITEK)
sg.finance.yahoo.com - August 10 at 8:36 AM
biz.yahoo.com logoINOTEK PHARMACEUTICALS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a (NASDAQ:ITEK)
biz.yahoo.com - August 10 at 8:36 AM
publicnow.com logoInotek Pharmaceuticals Corporation Reports Second Quarter 2016 Financial Results and Operational Highlights (NASDAQ:ITEK)
www.publicnow.com - August 10 at 8:36 AM
biz.yahoo.com logoINOTEK PHARMACEUTICALS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and (NASDAQ:ITEK)
biz.yahoo.com - August 5 at 5:52 PM
kcregister.com logoEye Catching Stocks: Apple Inc. (NASDAQ:AAPL), Inotek Pharmaceuticals Corporation (NASDAQ:ITEK), Itau Unibanco ... - KC Register (NASDAQ:ITEK)
www.kcregister.com - August 4 at 6:01 PM
News IconFiat Chrysler reports flat sales for July (NASDAQ:ITEK)
nanonews.org - August 3 at 6:01 PM
biz.yahoo.com logoINOTEK PHARMACEUTICALS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial S (NASDAQ:ITEK)
biz.yahoo.com - August 3 at 8:56 AM
kcregister.com logoSilicom Ltd. (NASDAQ:SILC) soared 5.74%: Inotek Pharmaceuticals Corporation (NASDAQ:ITEK), KeyCorp. (NYSE ... - KC Register (NASDAQ:ITEK)
www.kcregister.com - August 2 at 5:56 PM
News IconWalgreens Boots Alliance Inc (NASDAQ:WBA) & Inotek Pharmaceuticals (NASDAQ:ITEK) Stocks Under Consideration - Money News (press release) (NASDAQ:ITEK)
www.newsismoney.com - August 2 at 5:56 PM
News IconInotek Pharmaceuticals Corp (NASDAQ:ITEK) Avoid Direct Dilution Of Its Stock - Scibility Media (NASDAQ:ITEK)
scibilitymedia.com - August 2 at 5:56 PM
publicnow.com logoInotek Pharmaceuticals Announces Pricing of $50.0 Million of 5.75% Convertible Senior Notes due 2021 (NASDAQ:ITEK)
www.publicnow.com - August 2 at 10:33 AM
investing.com logoU.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.15% (NASDAQ:ITEK)
www.investing.com - August 1 at 5:37 PM
investors.com logoInotek Pharmaceuticals to raise US$50mln through convertible issue (NASDAQ:ITEK)
www.proactiveinvestors.com - August 1 at 10:28 AM
publicnow.com logoInotek Pharmaceuticals Announces Proposed Public Offering of $50 Million of Convertible Senior Notes due 2021 (NASDAQ:ITEK)
www.publicnow.com - August 1 at 7:11 AM
biz.yahoo.com logoINOTEK PHARMACEUTICALS CORP Files SEC form 8-K, Results of Operations and Financial Condition (NASDAQ:ITEK)
biz.yahoo.com - August 1 at 7:09 AM
ftsenews.co.uk logoInotek Pharmaceuticals Corporation (ITEK) Updated Price Targets - FTSE News (NASDAQ:ITEK)
www.ftsenews.co.uk - July 27 at 8:31 AM
investornewswire.com logoIs $40 Price Target Attainable For Inotek Pharmaceuticals Corporation (NASDAQ:ITEK)? - Investor Newswire (NASDAQ:ITEK)
www.investornewswire.com - July 23 at 9:43 AM
News IconInotek Pharmaceuticals Corporation (NASDAQ:ITEK): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:ITEK)
www.engelwooddaily.com - July 22 at 5:38 PM
publicnow.com logoInotek Pharmaceuticals Expands Intellectual Property Portfolio with Combination Patent (NASDAQ:ITEK)
www.publicnow.com - July 22 at 8:18 AM
News IconInotek Pharmaceuticals Corporation (NASDAQ:ITEK) Shorted Shares Increased By 110.52% - Consumer Eagle (NASDAQ:ITEK)
www.consumereagle.com - July 21 at 11:45 AM
kcregister.com logoActive Stocks to Watch: Inotek Pharmaceuticals Corporation (NASDAQ:ITEK), REEDS, Inc. (NYSEMKT:REED), WGL ... - KC Register (NASDAQ:ITEK)
www.kcregister.com - July 20 at 8:43 AM
News IconEquity Roundup: Stock Performance Focus on Inotek Pharmaceuticals Corporation (NASDAQ:ITEK) - Press Telegraph (NASDAQ:ITEK)
presstelegraph.com - July 20 at 8:43 AM
kcregister.com logoInotek Pharmaceuticals Corporation (NASDAQ:ITEK) increased 3.12%: Tesaro, Inc. (NASDAQ:TSRO), Yahoo! Inc ... - KC Register (NASDAQ:ITEK)
www.kcregister.com - July 19 at 11:49 AM
seekingalpha.com logoHere's Why We Are Avoiding Inotek Pharmaceuticals (NASDAQ:ITEK)
seekingalpha.com - July 18 at 5:53 PM

Social

Inotek Pharmaceuticals Corp. (NASDAQ:ITEK) Chart for Saturday, October, 1, 2016


Last Updated on 10/1/2016 by MarketBeat.com Staff